HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of an integrated intervention package of preventive chemotherapy, community-led total sanitation and health education on the prevalence of helminth and intestinal protozoa infections in Côte d'Ivoire.

AbstractBACKGROUND:
Preventive chemotherapy with donated anthelminthic drugs is the cornerstone for the control of helminthiases. However, reinfection can occur rapidly in the absence of clean water and sanitation coupled with unhygienic behaviour. The purpose of this study was to assess the effect of an integrated package of interventions, consisting of preventive chemotherapy, community-led total sanitation (CLTS) and health education, on the prevalence of helminth and intestinal protozoa infections and on participants' knowledge, attitude, practice and beliefs (KAPB) towards these diseases including water, sanitation and hygiene (WASH).
METHODS:
A cross-sectional survey was carried out in nine communities of south-central Côte d'Ivoire to assess people's infection with helminths and intestinal protozoa and KAPB. Subsequently, interventions were targeted to five communities, while the remaining communities served as control. The intervention encouraged latrine construction and an evaluation was done 6-7 months later to determine open defecation status of the respective communities. Anthelminthic treatment was provided to all community members. A follow-up cross-sectional survey was conducted approximately one year later, using the same procedures.
RESULTS:
Overall, 810 people had complete baseline and follow-up data and were given anthelminthic treatment. The baseline prevalence of hookworm, Schistosoma haematobium, Trichuris trichiura, Schistosoma mansoni and Ascaris lumbricoides was 31.1%, 7.0%, 2.0%, 1.0% and 0.3%, respectively. Four of the five intervention communities were classified open-defecation free. For hookworm infection, we observed higher negative changes in terms of proportion of decrease (-0.10; 95% confidence interval (CI): - 0.16, -0.04) and higher egg reduction rate (64.9 vs 15.2%) when comparing intervention with control communities. For intestinal protozoa, prevalence reduction was higher in intervention compared to control communities (8.2 vs 2.6%) and WASH indicators and intervention outcomes associated with lower odds for infection at follow-up. The intervention significantly impacted on reported latrine use (before: 15.5%, after: 94.6%), open defecation in the community surroundings (before: 75.0%, after: 16.7%) and awareness for environmental contamination through open defecation (before: 20.4%, after: 52.2%).
CONCLUSIONS:
An integrated package of interventions consisting of preventive chemotherapy, health education and CLTS reduces the prevalence of helminth and intestinal protozoa infection. Additional studies in other social-ecological settings are warranted to confirm our findings.
AuthorsEveline Hürlimann, Kigbafori D Silué, Fabien Zouzou, Mamadou Ouattara, Thomas Schmidlin, Richard B Yapi, Clarisse A Houngbedji, Kouassi Dongo, Bernadette A Kouadio, Siaka Koné, Bassirou Bonfoh, Eliézer K N'Goran, Jürg Utzinger, Cinthia A Acka-Douabélé, Giovanna Raso
JournalParasites & vectors (Parasit Vectors) Vol. 11 Issue 1 Pg. 115 (02 27 2018) ISSN: 1756-3305 [Electronic] England
PMID29486790 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anthelmintics
Topics
  • Adolescent
  • Adult
  • Animals
  • Anthelmintics (therapeutic use)
  • Child
  • Child, Preschool
  • Cote d'Ivoire (epidemiology)
  • Cross-Sectional Studies
  • Feces (parasitology)
  • Female
  • Health Education
  • Helminthiasis (epidemiology, prevention & control, therapy)
  • Humans
  • Intestinal Diseases, Parasitic (epidemiology, prevention & control, therapy)
  • Male
  • Middle Aged
  • Prevalence
  • Protozoan Infections (epidemiology, prevention & control, therapy)
  • Sanitation (methods)
  • Surveys and Questionnaires
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: